Atlas Trials

Measuring of the Duration of Action of Different Doses of Rocuronium-induced Neuromuscular Block in Infants During Surgical Treatment of Craniosynostosis

Clinical trial NCT07080528 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT07080528
Sponsor
Tamas Vegh, MD
Status
ENROLLING_BY_INVITATION
Phase
Phase 4
Study type
INTERVENTIONAL
Neuromuscular Blocking AgentsResidual Neuromuscular BlockNeuromuscular Blockade Monitoring
Start date
2024-07-06
Primary completion
2025-08-30
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.